^○Ezgi Ozdemir¹, Ryo Yamasaki¹, Satoshi Nagata¹, Hiroo Yamaguchi¹, Yuko Nakamuta¹, Katsuhisa Masaki¹, Jun-ichi Kira² (1.Kyushu University, Japan, 2.International University of Health and Welfare)

^○Fumitaka Shimizu¹, Ryo Ogawa², Toshiyuki Takahashi², Yukio Takeshita¹, Tatsuro Misu², Yasuteru Sano¹, Toshihiko Maeda¹, Ichiro Nakashima³, Kazuo Fujihara⁴, Takashi Kanda¹ (1.Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan, 2.Department of Neurology, Tohoku University Graduate School of Medicine, 3.Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)

^○Satoshi Nagata¹, Ryo Yamasaki¹, Yuko Nakamuta¹, Ezgi Ozdemir¹, Hiroo Yamaguchi¹, Katsuhisa Masaki¹, Jun-ichi Kira^2,3 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, 3.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital)

^○Yuki Matsumoto¹, Kimihiko Kaneko², Tatsuro Misu¹, Chihiro Namatame¹, Yoshiki Takai¹, Shuhei Nishiyama¹, Hiroshi Kuroda¹, Toshiyuki Takahashi³, Kazuo Fujihara^4,5, Masashi Aoki¹ (1.Tohoku University Graduate School of Medicine, Department of Neurology, Sendai, Japan, 2.Japanese Red Cross Ishinomaki Hospital, Department of Neurology, Ishinomaki, Miyagi, Japan, 3.National Hospital Organization Yonezawa Hospital, Department of Neurology, Yonezawa, Yamagata, Japan, 4.Fukushima Medical University, Department of Multiple Sclerosis Therapeutics, 5.Southern Tohoku Research Institute for Neuroscience, Multiple Sclerosis & Neuromyelitis Optica Center, Fukushima, Japan.)

^○Ryusei Nishigori^1,2, Mio Hamatani^2,3, Shinji Ashida⁴, Masaki Takata^1,2, Chihiro Fujii⁴, Kazuyuki Kawamura⁵, Hirofumi Ochi⁶, Ryosuke Takahashi¹, Hideki Ueno², Takayuki Kondou³ (1.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan, 2.Department of Immunology, Graduate School of Medicine, Kyoto University, Japan, 3.Department of Neurology, Medical Center, Kansai Medical University, 4.Department of Neurology, Graduate School of Medicine, Kyoto Prefectural University of Medicine, 5.Department of Neurology, Minami Kyoto Hospital, 6.Department of Neurology, Graduate School of Medicine, Ehime University)

^○Mitsuru Watanabe¹, David Leppert², Noriko Isobe¹, Takuya Matsushita¹, Aleksandra Maceski², Dimitri Rey², Sandra Mitrovic³, Yuri Nakamurar^1,4,5, Katsuhisa Masaki¹, Jun-ichi Kira^1,4,6, Jens Kuhle² (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, 3.Laboratory Medicine, University Hospital Basel, University of Basel, 4.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, 5.School of Pharmacy at Fukuoka, International University of Health and Welfare, 6.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare)